Menu Back to Biosimilars-Workshop


Biosimilar medicines' developments are maintaining their momentum, and the 2018 Biosimilars Conference programme delves into strategic discussions regarding:

  • Market access and regulatory developments in the EU and globally
  • National policy developments (e.g. education, incentives, government investments)
  • The impact of biosimilar medicines on the competitive landscape of biological products and the sustainability of the biosimilar medicines sector

As the 5th conference of its kind, the 2018 programme will provide current updates and challenges related to biosimilar medicines. The conference will consist of plenary sessions and multi-stakeholder panel discussions, which will allow for interaction with the audience. Participants will leave the conference with a wealth of new information and an expanded network of contacts.

Download Programme

Featured topics

  • Current regulatory status of biosimilar medicines in the EU
  • Regional updates from the US, Middle East and Africa
  • Advances and convergence of regulatory science
  • Market penetration
  • Sustainability of the biosimilar medicines sector
  • Biologics in practice: managing multi-source product exchange
  • Statistical approaches to quality comparability

Who should attend?

  • Professionals working in Regulatory Affairs and Market Access
  • Health care professionals
  • Patient advocates
  • Regulators
  • Decision makers

Learning objectives

  • Update the participants on the current knowledge including regulatory and scientific thinking
  • Deal with regulatory requirements, scientific and operational challenges
  • Exchange experiences and discuss hot topics with experts
  • Frame the current issues and create dialogue

Program Committee

  • Steffen  Thirstrup, MD, PhD
    Steffen Thirstrup, MD, PhD Director, NDA Regulatory Advisory Board
    NDA Advisory Services, United Kingdom
  • Julie  Marechal-Jamil, MSc
    Julie Marechal-Jamil, MSc Director, Biosimilar Policy & Science
    Medicines For Europe, Belgium
  • Aimad  Torqui, MSc
    Aimad Torqui, MSc Director, Global Regulatory Policy
    MSD, Netherlands
  • Arnold G. Vulto, PharmD, PhD
    Arnold G. Vulto, PharmD, PhD Professor of Hospital Pharmacy & Practical Therapeutics
    Erasmus University Medical Center Rotterdam, Netherlands
Load More

Digital Learning Catalog

DIA Learning: 2018 eLearning Soultions